Docaravimab Usage And Synthesis

Uses

Docaravimab is an antibody, targeting ERA (Evelyn-Rockitniki-Abelseth) glycoprotein ectodomain epitope G-III. Docaravimab can be used in research of Rabies[1].

References

[1] Wilkinson I, et, al. Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names. MAbs. 2022 Jan-Dec;14(1):2123299. DOI:10.1080/19420862.2022.2123299

Docaravimab(2247196-23-0)Related Product Information

• Coltuximab Ravtansine
• Ivonescimab
• Rivabazumab
• Research Grade Acazicolcept (DHC83404)
• dinutuximab
• Immunoglobulin G1, anti-(human interferon g) (human-mouse monoclonal HuZAF g1-chain), disulfide with human-mouse monoclonal HuZAF light chain, dimer
• Rocatinlimab
• Opucolimab
• Tilogotamab
• Miromavimab